Abstract
Background
The objective of this study was to determine the incidence and cause of disease-specific death in patients with mucoepidermoid carcinoma (MEC) affecting the major salivary glands.
Methods
A total of 94 patients with MEC treated at Memorial Sloan-Kettering Cancer Center between 1985 and 2009 were identified from a preexisting database of 451 patients with major salivary gland cancer. Patient, tumor, and treatment characteristics were recorded from a retrospective analysis of patient charts. There were 49 males (52 %), and the median age was 57 years (range, 9–89 years). Of the 94 patients, 49 % had low, 22 % had intermediate, and 28 % had high-grade carcinoma. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) were calculated using the Kaplan–Meier method. Cause of death was determined by chart review. Predictors of DSS were identified by univariate analysis.
Results
With a median follow-up of 59 months (range, 1–257), the 5-year OS, DSS, and RFS for all patients were 76 %, 83 %, and 79 %, respectively. DSS was significantly poorer for high-grade MEC compared with low/intermediate-grade MEC (5-year DSS 37 % vs 100 %, P < .001). There were 9 disease-specific deaths. The cause of death in 7 patients was distant metastatic disease with locoregional recurrence accounting for death in only 2 patients.
Conclusion
Outcome in patients with mucoepidermoid cancers of the major salivary glands is generally good. Mortality occurs almost exclusively in patients with high-grade tumors. The cause of death in the majority of patients is distant metastatic disease rather than locoregional recurrence.
Similar content being viewed by others
References
Mussi RK, Toro IF, Pereira MC. Mucoepidermoid carcinoma of the trachea mimicking asthma. J Bras Pneumol. 2009;35:280–4.
Shailendra S, Elmuntser A, Philip R, Prepageran N. High grade mucoepidermoid carcinoma of the middle ear treated with extended temporal bone resection. Med J Malaysia. 2008;63:247–8.
Tao H, Sano Y, Yamane M, Toyooka S, Oto T, Date H. Bronchial mucoepidermoid carcinoma with recurrent hemoptysis in a pregnant woman: report of a case. Surg Today. 2008;38:850–2.
Arakawa Y, Shimada M, Ikegami T, Kubo T, Imura S, Morine Y, et al. Mucoepidermoid carcinoma of the liver: report of a rare case and review of the literature. Hepatol Res. 2008;38:736–42.
Yasuda M, Yasukawa T, Ozaki D, Yusa T. Mucoepidermoid carcinoma of the thymus. Jpn J Thorac Cardiovasc Surg. 2006;54:23–6.
Calis AB, Coskun BU, Seven H, Sayin I, Basak T. Laryngeal mucoepidermoid carcinoma: report of two cases. Auris Nasus Larynx. 2006;33:211–4.
Layfield LJ, Liu K. Mucoepidermoid carcinoma arising in the glans penis. Arch Pathol Lab Med. 2000;124:148–51.
Sato H, Kuroda M, Maruta M, Maeda K, Koide Y. Mucoepidermoid carcinoma of the ascending colon: report of a case. Surg Today. 2002;32:1004–7.
Karakoc D, Ozdemir A, Hamaloglu E, Ozenc A, Sokmensuer C. Mucoepidermoid carcinoma of the thyroid and the parotid glands. Am Surg. 2009;75:519–20.
Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008;44:407–17.
Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8:177–84.
Spitz MR, Batsakis JG. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110:45–9.
Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82:1217–24.
Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Mäkitie A, et al. Salivary gland cancer in Finland 1991–96: an evaluation of 237 cases. Acta Otolaryngol. 2005;125:207–14.
Ostman J, Anneroth G, Gustafsson H, Tavelin B. Malignant salivary gland tumours in Sweden 1960–1989—an epidemiological study. Oral Oncol. 1997;33:169–76.
Wahlberg P, Anderson H, Biorklund A, Möller T, Perfekt R. Carcinoma of the parotid and submandibular glands–a study of survival in 2465 patients. Oral Oncol. 2002;38:706–13.
Onyango JF, Awange DO, Muthamia JM, Muga BI. Salivary gland tumours in Kenya. East Afr Med J. 1992;69:525–30.
Stewart FW, Foote FW, Becker WF. Muco-epidermoid tumors of salivary glands. Ann Surg. 1945;122:820–44.
Yang S, Chen X. Calcifications in clear cell mucoepidermoid carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:274–5.
Thackray AC, Sobin L.H. Histological typing of salivary gland tumours. In International Histological Classification of Tumours. No. 7. Geneva: World Health Organization; 1972.
Kini YK, Halli R, Mishra S, Kalburge JV. Comprehensive management of a rare carcinoma ex pleomorphic adenoma of the lacrimal gland with a modified lateral orbitotomy access osteotomy. A case report. Oral Maxillofac Surg. 2012;16:123–6.
Ghosh-Laskar S, Murthy V, Wadasadawala T, Agarwal J, Budrukkar A, Patil N, et al. Mucoepidermoid carcinoma of the parotid gland: Factors affecting outcome. Head Neck. 2011;33:497–503.
Guzzo M, Andreola S, Sirizzotti G, Cantu G. Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol. 2002;9:688–95.
Aro K, Leivo I, Makitie AA. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution’s 30-year experience. Laryngoscope. 2008;118:258–62.
Nance MA, Seethala RR, Wang Y, Chiosea SI, Myers EN, Johnson JT, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008;113:2082–9.
Villavicencio-Ayala B, Resendiz-Colosia JA, Labastida-Almendaro S, Torres-Núñe MG, Peña-Torres LM, Gallegos-Hernández JF. [Prognostic factors in head and neck mucoepidermoid carcinoma]. Cir Cir. 2008;76:109–17 (in Spanish).
Spiro RH, Huvos AG, Berk R, Strong EW. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg. 1978;136:461–8.
Bhattacharyya N, Fried MP. Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg. 2002;128:904–8.
Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck–a 20 years experience. Int J Oral Maxillofac Surg. 2004;33:25–31.
Medina JE. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am. 1998;31:815–22.
Weber RS, Byers RM, Petit B, Wolf P, Ang K, Luna M. Submandibular gland tumors. Adverse histologic factors and therapeutic implications. Arch Otolaryngol Head Neck Surg. 1990;116:1055–60.
McNaney D, McNeese MD, Guillamondegui OM, Fletcher GH, Oswald MJ. Postoperative irradiation in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys. 1983;9:1289–95.
Locati LD, Bossi P, Perrone F, Potepan P, Crippa F, Mariani L, et al. Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study. Oral Oncol. 2009;45:574–8.
Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope. 2001;111:1373–8.
Zyada MM, Grawish ME, Elsabaa HM. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma. Ann Diagn Pathol. 2009;13:313–21.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ali, S., Sarhan, M., Palmer, F.L. et al. Cause-Specific Mortality in Patients with Mucoepidermoid Carcinoma of the Major Salivary Glands. Ann Surg Oncol 20, 2396–2404 (2013). https://doi.org/10.1245/s10434-013-2872-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-013-2872-2